Browse our range of reports and publications including performance and financial statement audit reports, assurance review reports, information reports and annual reports.
Onshore vaccine manufacturing facilities

Please direct enquiries through our contact page.
The objective of this audit is to examine the effectiveness of the procurement and contract management of onshore-manufactured antivenoms and vaccines.
Audit criteria
The ANAO proposes to examine:
- Was the 2020–21 procurement of Seqirus antivenoms, Q fever vaccines, and influenza vaccines effective?
- Was the 2021–22 procurement of Moderna onshore mRNA vaccines effective?